London, United Kingdom

Ivan Milivojevic

This inventor holds 41 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Breathing Assistance Devices. Top assignees: Fisher & Paykel Healthcare Limited, Vectura Delivery Devices Limited, Boehringer Ingelheim International Gmbh. Active years: 2004-2023.

USPTO Granted Patents = 41 

% Patents Active = 80.5


 

Average Co-Inventor Count = 4.0

ph-index = 19

Forward Citations = 1,447(Granted Patents)


Location History:

  • Auckland, NL (2007)
  • Newmarket, GB (2014)
  • Chippenham, GB (2016)
  • Cambridge, GB (2011 - 2018)
  • Auckland, NZ (2004 - 2023)
  • London, GB (2008 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Breathing Assistance
Inhaler
Mask
Patient Interfaces
Nasal Masks
Connector
Cover
Apparatus
41 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ivan Milivojevic

Introduction: Ivan Milivojevic is a visionary inventor based in London, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ivan Milivojevic holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a background in engineering and a passion for problem-solving, Ivan Milivojevic has led numerous successful projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Ivan Milivojevic has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Ivan Milivojevic's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…